Drug intelligence / Profile preview

Zi-Yin-Liang-Ge-San

Development stage
Phase 2
Administration
Oral
01

Overview

Zi-Yin-Liang-Ge-San appears to be a variant of Liang-Ge-San (LGS), a classic traditional Chinese medicine formula first described in *Taiping Huimin Heji Jufang* (Song dynasty, c. 1107 AD). It contains multiple herbs, with Forsythia Fruits (Lian Qiao) as the principal ingredient. The formula is designed to clear heat and fire according to traditional Chinese medicine principles. It is widely used to treat various inflammatory conditions including: - Acute lung injury - Pharyngitis - Amygdalitis - Pneumonia - Sepsis Research has shown that Liang-Ge-San exerts potent anti-inflammatory effects through several mechanisms, such as: 1. Suppressing the production of pro-inflammatory cytokines IL-6 and TNF-α. 2. Inhibiting the degradation and phosphorylation of IκBα and the nuclear translocation of NF-κB p65. 3. Activating the α7 nicotinic cholinergic receptor (α7nAchR). 4. Up-regulating miR-21 expression, leading to suppression of the STAT3 signaling pathway. 5. Potentially inhibiting glycogen synthase kinase-3β (GSK-3β). For adult patients, the typical dosage mentioned is 200 ml of Liang-Ge-San decoction at a concentration of 0.195 g/ml, taken orally twice per day. The formula is also available in various forms, including pills marketed under names like "Cool Valley" (Liang Ge San Wan).

Brand names
Cool Valley
Other names
Liang-Ge-SanLGS
02

Targets

miR-21 (MicroRNA-21)TNFA (Tumor necrosis factor alpha (soluble))STAT3 (Signal Transducer and Activator of Transcription 3)IL-6 (Interleukin 6)CHRNA7 (α7 nicotinic receptor)NF-κBGSK3 (Glycogen synthase kinase 3 beta)

Beyond the preview

Go deeper on Zi-Yin-Liang-Ge-San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zi-Yin-Liang-Ge-San.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call